Basic Information
Xenikos is developing a new therapy that enables patients with severe immune disorders or post-transplant rejection to quickly and effectively reset their immune systems. Xenikos' mission is to develop novel, innovative immunotherapeutic drugs to help restore patients' health and save lives.
Xenikos B.V.
Nijmegen,Gelderland,Netherlands
less than 15 people
January 01, 2009
info@xenikos.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios